Player FM - Internet Radio Done Right
Checked 22d ago
הוסף לפני two שנים
תוכן מסופק על ידי i3 Health and I3 Health. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי i3 Health and I3 Health או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.
Player FM - אפליקציית פודקאסט
התחל במצב לא מקוון עם האפליקציה Player FM !
התחל במצב לא מקוון עם האפליקציה Player FM !
Additional Advances in Graft-Versus-Host Disease Research and Clinical Trials: Shernan Holtan, MD
Manage episode 357636646 series 3456244
תוכן מסופק על ידי i3 Health and I3 Health. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי i3 Health and I3 Health או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.
In 2022, Dr. Shernan Holtan, Associate Professor at the University of Minnesota Medical School, recorded a CME/NCPD activity centered on new therapeutic avenues for improved patient outcomes in graft-versus-host-disease (GVHD). Recently, at the American Society of Hematology (ASH) Annual Meeting, she presented results of the BMT CTN 1703 trial, which investigated the efficacy of a GVHD prophylaxis regimen. While there, Dr. Holtan sat down with Oncology Data Advisor to discuss the potential of these results to change GVHD prophylaxis, as well as the other significant GVHD research presented at the meeting. Click here to view and claim credit for New Opportunities for Improved Patient Outcomes in Graft-Versus-Host Disease, an accredited CME/NCPD activity provided by i3 Health: https://i3health.com/gvhd
…
continue reading
44 פרקים
Manage episode 357636646 series 3456244
תוכן מסופק על ידי i3 Health and I3 Health. כל תוכן הפודקאסטים כולל פרקים, גרפיקה ותיאורי פודקאסטים מועלים ומסופקים ישירות על ידי i3 Health and I3 Health או שותף פלטפורמת הפודקאסט שלהם. אם אתה מאמין שמישהו משתמש ביצירה שלך המוגנת בזכויות יוצרים ללא רשותך, אתה יכול לעקוב אחר התהליך המתואר כאן https://he.player.fm/legal.
In 2022, Dr. Shernan Holtan, Associate Professor at the University of Minnesota Medical School, recorded a CME/NCPD activity centered on new therapeutic avenues for improved patient outcomes in graft-versus-host-disease (GVHD). Recently, at the American Society of Hematology (ASH) Annual Meeting, she presented results of the BMT CTN 1703 trial, which investigated the efficacy of a GVHD prophylaxis regimen. While there, Dr. Holtan sat down with Oncology Data Advisor to discuss the potential of these results to change GVHD prophylaxis, as well as the other significant GVHD research presented at the meeting. Click here to view and claim credit for New Opportunities for Improved Patient Outcomes in Graft-Versus-Host Disease, an accredited CME/NCPD activity provided by i3 Health: https://i3health.com/gvhd
…
continue reading
44 פרקים
כל הפרקים
×i
i3 Health Podcast
1 Best Practices and Emerging Evidence in the Treatment of Atopic Dermatitis in Children and Adolescents 35:40
35:40
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי
35:40Tune in to the latest podcast episode, Best Practices and Emerging Evidence in the Treatment of Atopic Dermatitis in Children and Adolescents, where experts Dr. Peter A. Lio and Dr. Linda F. Stein Gold discuss cutting-edge advancements in pediatric AD care. Learn about new therapies, including nonsteroidal topicals, JAK inhibitors, monoclonal antibodies, and emerging treatments targeting the OX40 pathway, along with practical strategies to optimize patient outcomes. This episode is a must-listen for dermatologists, pediatricians, family medicine physicians, nurse practitioners, PAs, nurses, and other healthcare providers looking to stay current on evidence-based care for children and adolescents with AD. Earn CME/NCPD credit while you listen! Click here to claim credit: i3health.com/atopic-dermatitis…
i
i3 Health Podcast
1 What’s New With HER2: Charting New Paths in NSCLC Care Module 1 Podcast: HER2 in NSCLC: Actionable Insights and Testing Recommendations 15:24
15:24
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי
15:24Stay ahead in NSCLC management with this accredited podcast! HER2 alterations, including gene mutations and protein overexpression, are key therapeutic targets, but their complexity can challenge treatment decisions. In Module 1 of this podcast, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, provides essential insights and testing recommendations to optimize patient care. Listen now!…
i
i3 Health Podcast
1 What’s New With HER2: Charting New Paths in NSCLC Care Module 2 Podcast 18:34
18:34
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי
18:34Stay ahead in NSCLC management with our accredited podccast! HER2 alterations, including gene amplifications, mutations, and protein overexpression, are critical therapeutic targets, but their heterogeneity can complicate treatment strategies. In Module 2, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, explores advanced testing methodologies and strategies to navigate HER2 complexities and optimize patient outcomes. Listen now!…
i
i3 Health Podcast
1 Diagnosis and Management of Dedifferentiated Liposarcoma: A Multidisciplinary Task Force Podcast 28:57
28:57
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי
28:57Gain valuable insights into the complexities of diagnosing and managing dedifferentiated liposarcoma (DDLPS) and earn free CME credit with our latest podcast. This episode features expert guidance from Dr. Richard F. Riedel of Duke University and Dr. Candace L. Haddox of Dana-Farber Cancer Institute. Delve into the latest on identifying MDM2 and CDK4 amplification, challenges in diagnosing DDLPS, and updates on emerging therapies like CDK4/6 inhibitors and immunotherapies. Learn how a multidisciplinary approach enhances patient outcomes in this rare and aggressive soft tissue sarcoma. Listen now and advance your expertise! Click here to claim your CME credit: https://i3health.com/course-information/podcast-ddlps…
i
i3 Health Podcast
1 National Alzheimer Disease Awareness Month: Advances in Diagnosis and Research With Nathaniel Chin, MD 14:25
14:25
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי
14:25Click the links below for the full activity! Online Accredited CME/NCPD Activity: https://i3health.com/course-information/Alzheimer-disease Live In-Person or Virtual Meeting: https://i3health.com/live/Exploring%20Advances%20in%20the%20Early%20Diagnosis%20and%20Treatment%20of%20Alzheimer%20Disease November is National Alzheimer Disease Awareness Month, a time to raise awareness of early warning signs, advocate for research, and show support for the more than 6.2 million Americans living with this disease. Dr. Nathaniel Chin, Associate Professor of Medicine in the Division of Geriatrics and Gerontology at the University of Wisconsin-Madison, is currently serving as chair of i3 Health’s accredited CME/NCPD activity, Exploring Advances in the Early Diagnosis and Treatment of Alzheimer Disease. In honor of National Alzheimer Disease Awareness Month, he sat down with us again to share recent advances in diagnosis and treatment, including those which listeners can learn more about in the activity,…
i
i3 Health Podcast
i3 Health is pleased to invite you to Pathways to Precision: Integrating Genetic Counseling and Testing Into Cancer Care, a free, live webinar held on November 7 at 10:00 am Eastern and November 19 at 11:30 am Eastern. This interview features an exclusive preview from the two webinar co-chairs, Dr. Filipa Lynce, Director of the Inflammatory Breast Center at Dana-Farber Cancer Center and Assistant Professor of Medicine at Harvard Medical School, and Catherine Skefos, Certified Genetic Counselor in the Clinical Cancer Genetics Program at the University of Texas MD Anderson Cancer Center. Click below to register for this insightful webinar and enhance your understanding of genetic testing and counseling in cancer care! Register for the webinar: https://i3health.com/course-information/pathways-to-precision-integrating-genetic-counseling-and-testing-into-cancer-care…
i
i3 Health Podcast
Dr. Deborah Wong, Director of the Medical Oncology Program and Clinical Trials Program for Head and Neck Squamous Cell Cancers (HNSCC) and an Associate Clinical Professor of Medicine at the University of California Los Angeles (UCLA) is currently serving as co-chair of i3 Health’s accredited CME/NCPD activity, Recurrent and Metastatic HNSCC, Harnessing Immunotherapy and Comprehensive Care. With new developments in the field occurring over recent months, Dr. Wong sat down with us again to share new updates in treatment and management of HNSCC. Click here for the full activity! https://i3health.com/course-information/hnscc-harnessing-immunotherapy-in-comprehensive-care…
i
i3 Health Podcast
1 Navigating Patients Through the CKD Journey by Enhancing Value-Based Care - CPE & Interview 1:55:41
1:55:41
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי
1:55:41Jeff Sperry, PharmD, BCPS, a Clinical Pharmacist at UCHealth Memorial Hospital, sat down with the Pharmacy Podcast Network to discuss additional advances in chronic kidney disease since recording the i3Health CPE-accredited activity, Slowing Progression of Chronic Kidney Disease Through Value-Based Care. Following the interview, continue listening for the complete CPE-accredited podcast. Click this link to claim your free CPE certificate: i3health.com/course-information…nic-kidney-disease…
i
i3 Health Podcast
1 Additional Advances in Alzheimer Disease Research and Clinical Trials With Nathaniel Chin, MD 14:18
14:18
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי
14:18Dr. Nathaniel Chin, Associate Professor of Medicine in the Division of Geriatrics and Gerontology at the University of Wisconsin-Madison, is currently serving as chair of i3 Health’s accredited CME/NCPD activity, Exploring Advances in the Early Diagnosis and Treatment of Alzheimer Disease. With new developments in the field occurring over recent months, Dr. Chin sat down with us again to share new updates in treatment and management of Alzheimer disease and what clinicians can look forward to learning more about in the online activity and webinars. Click the links below for the full activity! Online Accredited CME/NCPD Activity: https://i3health.com/course-information/Alzheimer-disease Live Webinar: https://i3health.com/course-information/exploring-advances-in-the-early-diagnosis-and-treatment-of-alzheimer-disease-webinar In-Person or Virtual Meeting: https://i3health.com/live/Exploring%20Advances%20in%20the%20Early%20Diagnosis%20and%20Treatment%20of%20Alzheimer%20Disease…
i
i3 Health Podcast
1 Mitigating Disease Burden and Health Care Disparities in Relapsed/Refractory MM 33:18
33:18
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי
33:18Listen now to this CME-accredited podcast, part of the Multiple Myeloma Task Force series, where we will explore strategies for mitigating disease burden and addressing health care disparities in patients with relapsed/refractory multiple myeloma. This session brings together expert insights from Task Force Co-Chairs, Dr. Sikander Ailawadhi, Professor of Medicine at Mayo Clinic, and Dr. Rahul Banerjee, Assistant Professor of Medical Oncology at Fred Hutchinson Cancer Center and the University of Washington. Their consensus-driven perspectives will provide valuable guidance on improving patient outcomes and equity in care for multiple myeloma.To learn more about the task force, read the position statement or revisit the youtube live please visit: https://i3health.com/course-information/podcast-rrmm…
i
i3 Health Podcast
1 Multicancer Early Detection Technologies: Module 3 - Implementing MCED Testing in Clinical Practice 23:43
23:43
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי
23:43Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application. In Module 3 of our CME podcast, Dr. Charles Vega, Clinical Professor at the University of California, Irvine, will review the latest clinical trial data on MCED tests for gynecologic, gastrointestinal, and hematologic cancers, offering valuable insights into how these innovations could transform cancer screening and improve patient outcomes. Claim your free CME credit here:…
i
i3 Health Podcast
1 Multicancer Early Detection Technologies: Module 1 - Science Behind Cancer Screening 20:16
20:16
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי
20:16Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application. Listen now to Module 1 and join Dr. Charles Vega, a distinguished Clinical Professor from UC Irvine, as he explores the cutting-edge realm of multicancer early detection (MCED). Dr. Vega will delve into the scientific foundations of blood-based cancer screening, highlighting both current limitations and the promising potential of MCED technologies. Learn how these revolutionary tests harness biomarkers to detect multiple cancers in a single, convenient screening—a game-changer in overcoming barriers like low awareness and limited access to screening facilities. Claim your free CME credit for this activity podcast here:…
i
i3 Health Podcast
1 Multicancer Early Detection Technologies: Module 2 - Clinical Evidence for MCED Testing 20:13
20:13
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי
20:13Discover the future of cancer screening with our exclusive CME podcast series, Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application. Join Dr. Charles Vega in Module 2 of our CME podcast as he delves into the cutting-edge world of multicancer early detection (MCED) tests. With nearly 2 million new cancer cases expected in 2024, the role of early detection has never been more critical. Dr. Vega will unpack the latest clinical trial data on MCED tests for gynecologic, gastrointestinal, and hematologic cancers, exploring their potential to revolutionize cancer screening and improve patient outcomes. Listen now and claim your free CME credit here:…
i
i3 Health Podcast
1 Additional Advances in Rett Syndrome Research and Clinical Trials With Timothy John Feyma, MD 5:00
Dr. Timothy John Feyma, Pediatric Neurologist at Gillette Children’s Hospital, is currently serving as chair of i3 Health’s CME/NCPD activity, Exploring Novel Treatments for Rett Syndrome. With new developments in the field occurring over recent months, Dr. Feyma sat down with us again to share new updates in treatment and management of Rett syndrome, words of advice for how clinicians can best care for their patients, and what he is most looking forward to seeing in Rett syndrome research in the coming years. Click here to view Dr. Feyma’s full CME/NCPD activity and claim credit: https://i3health.com/course-information/rett-syndrome Click here to register for a live webinar presented by Dr. Feyma: https://i3health.com/course-information/rett-syndrome-webinar Click here to bring an in-person or virtual meeting to your own institution: https://i3health.com/live/exploring-novel-treatments-for-rett-syndrome-2…
i
i3 Health Podcast
1 Practice-Changing Advances in the Management of Hemophilia 42:37
42:37
הפעל מאוחר יותר
הפעל מאוחר יותר
רשימות
לייק
אהבתי
42:37In this podcast, hear expert perspectives on practice-changing advances in the treatment and personalized management of patients with hemophilia from Dr. Guy Young, Director of the Hemostasis and Thrombosis Program, Attending Physician in Hematology/Oncology, and Professor of Pediatrics at Keck School of Medicine of USC; and Dr. Jennifer Davila, Co-Director of the Hemophilia Treatment Center at Montefiore and Associate Professor of Pediatrics at The Children's Hospital at Montefiore. Listen to the episode now!…
ברוכים הבאים אל Player FM!
Player FM סורק את האינטרנט עבור פודקאסטים באיכות גבוהה בשבילכם כדי שתהנו מהם כרגע. זה יישום הפודקאסט הטוב ביותר והוא עובד על אנדרואיד, iPhone ואינטרנט. הירשמו לסנכרון מנויים במכשירים שונים.